Mark Williams MD

Mark Williams, MD, FCCM, FCCP, is a leading patient safety expert in global oncology at Eli Lilly and Company. With over 28 years of experience in internal medicine, Williams has advanced from a Senior Medical Director focused on COVID-19, obesity, and cardiovascular drug development to Associate Vice President of Global Patient Safety for Medical Oncology. Williams has held notable positions as Chief Medical Officer at Asahi Kasei Pharma America and La Jolla Pharmaceutical Company, as well as a Field Medical Director at Astute Medical. Concurrently, Williams serves as a Clinical Associate Professor at Indiana University, contributing to the education of future medical professionals.